Bluestone JA - Search Results

1

A comprehensive review of interventions in the NOD mouse and implications for translation.

Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. Shoda LK, et al. Among authors: bluestone ja. Immunity. 2005 Aug;23(2):115-26. doi: 10.1016/j.immuni.2005.08.002. Immunity. 2005. PMID: 16111631 Free article. Review.

2

The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.

Shoda L, Kreuwel H, Gadkar K, Zheng Y, Whiting C, Atkinson M, Bluestone J, Mathis D, Young D, Ramanujan S. Shoda L, et al. Clin Exp Immunol. 2010 Aug;161(2):250-67. doi: 10.1111/j.1365-2249.2010.04166.x. Epub 2010 May 18. Clin Exp Immunol. 2010. PMID: 20491795 Free PMC article.

3

Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Bluestone JA, Herold K, Eisenbarth G. Bluestone JA, et al. Nature. 2010 Apr 29;464(7293):1293-300. doi: 10.1038/nature08933. Nature. 2010. PMID: 20432533 Free PMC article. Review.

4

Expansion of human regulatory T-cells from patients with type 1 diabetes.

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Putnam AL, et al. Among authors: bluestone ja. Diabetes. 2009 Mar;58(3):652-62. doi: 10.2337/db08-1168. Epub 2008 Dec 15. Diabetes. 2009. PMID: 19074986 Free PMC article.

5

How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited.

Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. Atkinson MA, et al. Among authors: bluestone ja. Diabetes. 2011 May;60(5):1370-9. doi: 10.2337/db10-1797. Diabetes. 2011. PMID: 21525508 Free PMC article. No abstract available.

6

NKG2D blockade prevents autoimmune diabetes in NOD mice.

Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, Lanier LL. Ogasawara K, et al. Among authors: bluestone ja. Immunity. 2004 Jun;20(6):757-67. doi: 10.1016/j.immuni.2004.05.008. Immunity. 2004. PMID: 15189740 Free article.

7

Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.

Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC. Seyfert-Margolis V, et al. Among authors: bluestone ja. Diabetes. 2006 Sep;55(9):2588-94. doi: 10.2337/db05-1378. Diabetes. 2006. PMID: 16936208 Clinical Trial.

8

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA. Tang Q, et al. Among authors: bluestone ja. Immunity. 2008 May;28(5):687-97. doi: 10.1016/j.immuni.2008.03.016. Epub 2008 May 8. Immunity. 2008. PMID: 18468463 Free PMC article.

9

Is antigen specificity of autoreactive T cells the key to islet entry?

Penaranda C, Bluestone JA. Penaranda C, et al. Among authors: bluestone ja. Immunity. 2009 Oct 16;31(4):534-6. doi: 10.1016/j.immuni.2009.09.006. Immunity. 2009. PMID: 19833083 Free article.

10

Mechanisms of PDL1-mediated regulation of autoimmune diabetes.

Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH. Guleria I, et al. Among authors: bluestone ja. Clin Immunol. 2007 Oct;125(1):16-25. doi: 10.1016/j.clim.2007.05.013. Epub 2007 Jul 12. Clin Immunol. 2007. PMID: 17627890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

535 results

Search Page